MedPath

Exercise Training Adherence After Cardiac Rehabilitation in Coronary Heart Disease Patients

Not Applicable
Completed
Conditions
Coronary Disease
Interventions
Behavioral: Exercise training
Other: Control
Registration Number
NCT01246570
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

It is known that organized cardiac rehabilitation is effective in improving exercise capacity in coronary heart disease patients. Less is known about the long-term results after cardiac rehabilitation. Earlier studies have shown that many patients quit exercising when no longer attending formal rehabilitation. The investigators wish to investigate the effect of a maintenance program after ending a rehabilitation program, and to compare this to usual care. The investigators hypothesis is that the maintenance program will result in higher exercise capacity and more physical activity compared to usual care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  • coronary heart disease patients
Exclusion Criteria
  • unstable angina pectoris
  • hemodynamic significant valve disease (> New York Heart Association class II)
  • pregnancy
  • left ventricular ejection fraction <30%
  • kidney failure (creatinin > 140)
  • uncontrolled hypertension

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Maintenance programExercise trainingPatients will attend a "motivational exercise session" once monthly. They will also be tested (exercise test with measurement of peak oxygen uptake) every third months.
ControlControlUsual care. The patients will receive the usual care provided by the hospital and community health services
Primary Outcome Measures
NameTimeMethod
Peak oxygen uptakebaseline and 12 months

The change in peak oxygen uptake from baseline to 12 months after baseline. In the intervention group, the peak oxygen uptake will be measured also every 3 months during the intervention period, and this will be reported

Secondary Outcome Measures
NameTimeMethod
Deathbaseline and 12 months
Endothelial functionbaseline and 12 months

Flow mediated dilatation of the brachial artery, measured by ultrasound. Changes in flow-mediated dilatation from baseline to 12 months after baseline will be recorded

Quality of lifebaseline and 12 months

Mac New health related quality of life questionnaire. Changes in quality of life from baseline to 12 months after baseline will be recorded

Myocardial infarctionbaseline and 12 months

Diagnosis of myocardial infarction during the intervention period will be recorded

Hospital readmissionbaseline and 12 months

It will be recorded whether the patients is readmitted to hospital during the intervention period

Blood markersbaseline and 12 months

Lipoproteins, c-peptide, ferritin, glucose, high sensitive c-reactive protein will be analysed. Also, blood will be stored for later analyses not yet planned. Changes in markers from baseline to 12 months after baseline will be recorded

Physical activitybaseline and 12 months

Questionnaire and physical activity sensor (armband) will be measured at baseline and after 12 months.

Trial Locations

Locations (1)

Norwegian University of Science and Technology

🇳🇴

Trondheim, Norway

© Copyright 2025. All Rights Reserved by MedPath